Belantamab Medication Information

Discover comprehensive details about Belantamab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Belantamab brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Belantamab

Pronunciation : bel an' ta mab

Brand Names or Trade Names of Belantamab

India :

Blenrep

Overview of Belantamab

Belantamab is an anticancer agent indicated for the treatment of adults with multiple myeloma who have received at least four previous therapies. Multiple myeloma is a cancer that arises from white blood cell called the plasma cell.

Why is Belantamab Prescribed? (Indications)

Belantamab is an anticancer agent indicated for the treatment of adults with multiple myeloma-A type of skin cancer.

When should Belantamab not be taken? (Contraindications)

Patients allergic to Belantamab
Pregnant and lactating women

What is the dosage of Belantamab?

Belantamab is available as an injection.
The recommended dosage is 2.5 mg/kg body weight, to be given as an intravenous infusion over half an hour once every 3 weeks.

How should Belantamab be taken?

Belnatamab is available for intravenous injection

What are the warnings and precautions for Belantamab?

•In case of any reactions, the dosage should be reduced to 1.9 mg/kg intravenously once every 3 weeks.

• Patients should undergo regular eye assessments while using this medication.

• Patients should monitor serum creatinine, glucose, complete blood counts regularly while using this medication. Safety of usage was not established in children.

What are the side effects of Belantamab?

General: Fatigue, Fever
Digestive: Nausea, vomiting, constipation, diarrhea, decreased appetite
Blood: Decreased platelet count, hemoglobin
Metabolic: Gamma glutamyl transferase levels may increase
Kidney: Creatinine levels may increase
Eye: corneal changes, decreased vision, blurred vision
Respiratory tract: Upper respiratory tract infection

What are the other precautions for Belantamab?

Patients with low platelet count should be careful. Regular platelet counts should be monitored.
Infusion-related reactions can occur. If a reaction occurs, the infusion must be discontinued.
In women who are able to get pregnant, proper contraceptives should be used during the treatment and one week after the last dose is given.